SLC2A13 and frontotemporal dementia: Another important potential target was the inhibition of the Solute Carrier Family 2 (Facilitated Glucose Transporter) Member 13 protein encoded by Slc2a13, recently identified a risk factor in frontotemporal dementia (Sirkis et al., 2019).